retatrutide gassy Medscape | Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is What Is Retatrutide? | Triple-Agonist

HistoIndexs AI-based fibrosis assessment uses advanced digital pathology techniques to provide detailed and precise analysis of liver tissue, helping to better understand fibrosis dynamics and treatment responses

California health officials said Medi-Cal members and their health care providers should consider other treatment options that can support weight loss, such as diet changes, increased activity or exercise, and counseling. That echoes advice from the New Hampshire Medicaid program

If approved by the FDA, lixisenatide will become the fourth GLP-1 agonist available on the market, following Victoza, Byetta, and Bydureon

FiorelliSPorroBCosentinoNDi MinnoAManegaCMFabbiocchiFet alActivation of Nrf2/HO-1 pathway and human atherosclerotic plaque vulnerability: an in vitro and in vivo study

J Cell Sci 115:20532065 Petit FM, Serres C, Bourgeon F et al (2013) Identification of sperm head proteins involved in zona pellucida binding